Gemigliptin, a novel dipeptidyl peptidase-IV inhibitor, exerts a synergistic cytotoxicity with the histone deacetylase inhibitor PXD101 in thyroid carcinoma cells.
J Endocrinol Invest
; 41(6): 677-689, 2018 Jun.
Article
in En
| MEDLINE
| ID: mdl-29147952
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperidones
/
Pyrimidines
/
Sulfonamides
/
Thyroid Neoplasms
/
Biomarkers, Tumor
/
Drug Synergism
/
Dipeptidyl-Peptidase IV Inhibitors
/
Histone Deacetylase Inhibitors
/
Hydroxamic Acids
Limits:
Humans
Language:
En
Journal:
J Endocrinol Invest
Year:
2018
Type:
Article